Pillstats
Rx only · Capsule, Delayed Release · Oral

Budesonide

Brands: Tarpeyo · Budesonide

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCA07EA06
RxCUI (US)19831
US makers4 labelers
Packages7
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.150$0.301$0.451$0.601Dec 2025Apr 2026Jul 2026
$0.498
Latest avg · Jul 22, 2026
-3%
Since Dec 17, 2025
4
Active US suppliers
71%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.7K5.4K8.1K11K2025 Q12025 Q22025 Q32025 Q42026 Q1
8.1K
Rx · 2026 Q1
746K
Units dispensed
-14%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Amneal Pharmaceuticals LLCunknown4SUPPLYING
Bryant Ranch Prepackrepackager1SUPPLYING
Amneal Pharmaceuticals of New York LLCunknown1SUPPLYING
Calliditas Therapeutics ABunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.